(Q69948496)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Benefits, risks and costs of immunization for measles, mumps and rubella (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

1 reference

1 reference

3

W A Orenstein

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

C C White

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

J P Koplan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 July 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Public Health

7 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

739-744

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

A benefit-cost analysis of mumps vaccine

7 October 2019

cites work

1 reference

12 December 2020

Clinical Evaluation of a New Measles-Mumps-Rubella Trivalent Vaccine

1 reference

12 December 2020

Benefits due to immunization against measles

1 reference

12 December 2020

Combined Live Measles, Mumps, and Rubella Virus Vaccines

1 reference

12 December 2020

Persistence of antibody in human subjects for 7 to 10 years following administration of combined live attenuated measles, mumps, and rubella virus vaccines

1 reference

12 December 2020

Hospitalizations for measles, 1970-78

1 reference

12 December 2020

Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis

1 reference

12 December 2020

Benefits, risks and costs of viral vaccines

1 reference

12 December 2020

Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination

1 reference

12 December 2020

Combined live measles, mumps, rubella vaccine. Immunological response

1 reference

12 December 2020

The economic value of life: linking theory to practice

1 reference

12 December 2020

Medical Importance of Measles

1 reference

12 December 2020

Benefit-cost analysis of rubella vaccination policy

1 reference

12 December 2020

The benefits from 10 years of measles immunization in the United States

1 reference

12 December 2020

Rubella vaccination in the United States: a ten-year review

1 reference

12 December 2020

Combined administration of measles, mumps, rubella, and trivalent oral poliovirus vaccines

1 reference

12 December 2020

Cost-benefits of measles eradication: effects of a federal intervention

1 reference

12 December 2020

Identifiers

DOI

10.2105/AJPH.75.7.739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3923849%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference